Subsequently to the publication of this article, the authors have contacted the Editorial Office to inform us that Fig. 6 on p. 3454 was inadvertently assembled incorrectly; essentially, the wrong immunofluorescence data were featured for the 'Control' experiment in Fig. 6A. The revised version of Fig. 6, now showing the correct data for the Control experiment in Fig. 6A, is shown on the next page. Note that this error did not affect either the results or the conclusions reported in this paper. The authors are grateful to the Editor of for allowing them the opportunity to publish this Corrigendum, and apologize both to the Editor and to readership for any inconvenience caused. [International Journal of Molecular Medicine 41: 3448‑3456, 2018; DOI: 10.3892/ijmm.2018.3539].
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3892/ijmm.2025.5514 | DOI Listing |
Histochem Cell Biol
March 2025
Department of Biochemistry, Larner College of Medicine, University of Vermont, 89 Beaumont Avenue, Burlington, VT, 05405, USA.
A major issue facing the field of cellular imaging, immunofluorescence (IF), and immunohistochemistry (IHC) microscopy is antibody quality. One of the main methods of antibody validation is testing on positive and negative control tissues with known expression levels of a given antigen. However, this approach is reliant on availability of tissues and reliable protein expression datasets, which are not always available.
View Article and Find Full Text PDFInt J Mol Med
May 2025
Clinical Hearing Center, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, P.R. China.
Subsequently to the publication of this article, the authors have contacted the Editorial Office to inform us that Fig. 6 on p. 3454 was inadvertently assembled incorrectly; essentially, the wrong immunofluorescence data were featured for the 'Control' experiment in Fig.
View Article and Find Full Text PDFInt J Oncol
April 2025
BK21+, Department of Cogno-Mechatronics Engineering, Pusan National University, Busan 609-735, Republic of Korea.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that a pair of data panels (namely, the A549T‑eto/FERO, 1 mM and FERO, 12 h panels) in the cell viability experiments shown in Fig. 1B on p. 1235 were partially overlapping, where the data had apparently been derived from the same original source.
View Article and Find Full Text PDFMol Med Rep
May 2025
Department of Urology Surgery, Zhongda Hospital, Southeast university, Nanjing, Jiangsu 210009, P.R. China.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell migration assay data shown in Fig. 2D on p. 5 were strikingly similar to data that had already been published in different form in the journal in an article written by different authors at different research institutes (which has subsequently been retracted).
View Article and Find Full Text PDFJ Nanobiotechnology
February 2025
Department of Cardiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Small interfering RNA (siRNA) therapies hold great potential for treating myocardial ischemia-reperfusion injury (MIRI); while their practical application is limited by the low bioavailability, off-target effects, and poor therapeutic efficacy. Here, we present an innovative engineered neutrophil membrane-camouflaged nanocomplex for targeted siRNA delivery and effective MIRI therapy. A nanoparticle (NP)-based siRNA delivery system, namely MNM/siRNA NPs, is camouflaged with neutrophil membranes modified by hemagglutinin (HA) and integrins.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!